Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
4(20%)
Results Posted
33%(3 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_4
5
25%
Ph not_applicable
3
15%
Ph phase_1
2
10%

Phase Distribution

2

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 4Post-market surveillance
5(50.0%)
N/ANon-phased studies
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

20

all time

Status Distribution
Active(5)
Completed(9)
Terminated(1)
Other(5)

Detailed Status

Completed9
unknown5
Recruiting4
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
4
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (20.0%)
Phase 45 (50.0%)
N/A3 (30.0%)

Trials by Status

not_yet_recruiting15%
recruiting420%
completed945%
terminated15%
unknown525%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT00060541

Evaluation and Treatment of Neurosurgical Disorders

Recruiting
NCT03952637Phase 1

A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis

Recruiting
NCT06664528

Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies

Recruiting
NCT06142968

Acute on Chronic Liver Failure in Cirrhotic Patients at Assiut University Hospitals

Not Yet Recruiting
NCT05718453Phase 1

Assessment of Trace Elements, Systemic Inflammation and Electrolytes

Completed
NCT04120168

Study Determining the Frequency of Duchenne Muscular Dystrophy and Late-onset Pompe Disease

Completed
NCT03696810Not Applicable

Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2

Completed
NCT05144672

Irisin And Diabetic Nephropathy

Unknown
NCT04903912

Campania Registry On Peripheral Artery Disease

Recruiting
NCT04794855

Risk Prediction Model of Preeclampsia

Unknown
NCT04621032

Obstructive Sleep Apnea Destabilizes Myocardial Repolarization Homogeneity

Completed
NCT04490772

Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19

Unknown
NCT03182699Phase 4

Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients

Completed
NCT01905748Not Applicable

Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine

Unknown
NCT00950170Phase 4

Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting

Completed
NCT03437109

Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus

Completed
NCT02106182Phase 4

Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia

Completed
NCT00914459Phase 4

Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients

Completed
NCT00884390Phase 4

Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings

Terminated
NCT01638039Not Applicable

Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections

Unknown

All 20 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
20